Vascular endothelial growth factor in preterm infants with respiratory distress syndrome

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Pediatric Pulmonology

• Publication date

  2005-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ppul.20205PMID 15786439
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Loss of HIF-2α and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice

  2002influential reference
• VEGF induces airway epithelial cell proliferation in human fetal lung in vitro.

  2001cited by this paper
• Differential expression of VEGF isoforms in mouse during development and in the adult

  2001cited by this paper
• Compartmentalization of Vascular Endothelial Growth Factor to the Epithelial Surface of the Human Lung

  2001cited by this paper
• Pulmonary vascular endothelial growth factor and Flt-1 in fetuses, in acute and chronic lung disease, and in persistent pulmonary hypertension of the newborn.

  2001influential reference
• VEGF is deposited in the subepithelial matrix at the leading edge of branching airways and stimulates neovascularization in the murine embryonic lung

  2000cited by this paper
• Vascular endothelial growth factor in human preterm lung.

  1999influential reference
• Vascular Endothelial Growth Factor in Pulmonary Lavage Fluid from Premature Infants: Effects of Age and Postnatal Dexamethasone

  1999cited by this paper
• Blood vessel formation: what is its molecular basis?

  1996cited by this paper
• Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues.

  1993cited by this paper
• Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors.

  1992cited by this paper
• A comparison of surfactant as immediate prophylaxis and as rescue therapy in newborns of less than 30 weeks' gestation.

  1991cited by this paper
• The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials

  1990cited by this paper
• Artificial surfactant therapy for hyaline membrane disease.

  1980cited by this paper
• A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants.

  1972cited by this paper
• Premature delivery of foetal lambs infused with glucocorticoids.

  1969cited by this paper
• Surface properties in relation to atelectasis and hyaline membrane disease.

  1959cited by this paper

• Risk factors and clinical outcomes of pulmonary hypertension associated with bronchopulmonary dysplasia in extremely premature infants: A systematic review and meta‐analysis

  2024cites this paper
• The association of LPCAT1-rs9728 polymorphism with cord blood IL-10, MIF, and VEGF levels in neonatal respiratory distress syndrome: a case–control study

  2024cites this paper
• Low Serum Vascular Endothelial Growth Factor Level Predicts Adverse Outcomes in Neonates with Respiratory Distress Syndrome

  2023cites this paper
• Molecular mechanisms underlying hyperoxia-induced lung fibrosis.

  2022cites this paper
• Perinatal Inflammatory Biomarkers and Respiratory Disease in Preterm Infants.

  2022cites this paper
• Plasma apelin and vascular endothelial growth factor levels in preterm infants: relationship to neonatal respiratory distress syndrome

  2022cites this paper
• Comparison of two different doses of intravitreal aflibercept in the treatment of retinopathy of prematurity.

  2021cites this paper
• Vascular endothelial growth factor response with propranolol therapy in patients with infantile hemangioma

  2021cites this paper
• Association of Maternal Preeclampsia with Neonatal Respiratory Distress Syndrome in Very-Low-Birth-Weight Infants

  2019cites this paper
• Lung Ultrasonography Score as a Respiratory Parameter of Respiratory Distress Syndrome in Very Preterm Infants: A Single Center Experience

  2019cites this paper
• Investigation of the maternal and cord plasma levels of IL-1 beta, TNF-alpha and VEGF in early membrane rupture

  2016cites this paper
• Sequestration of Vascular Endothelial Growth Factor (VEGF) Induces Late Restrictive Lung Disease

  2016cites this paper
• Nouvelles approches thérapeutiques de la pathologie pulmonaire par les suppléments alimentaires en période périnatale

  2015cites this paper
• Angiogenic Factors in Cord Blood of Preterm Infants Predicts Subsequently Developing Bronchopulmonary Dysplasia.

  2015cites this paper
• Vascular endothelial growth factor: therapeutic possibilities and challenges for the treatment of ischemia.

  2015cites this paper
• Vascular Endothelial Growth Factor/Placental Growth Factor Heterodimer Levels in Preterm Infants with Bronchopulmonary Dysplasia

  2015cites this paper
• 2014 IBD Update Symposium

  2014cites this paper
• Is vitamin d deficiency a risk factor for respiratory distress syndrome?

  2013cites this paper
• The role of VEGF and its soluble receptor VEGFR-1 in preterm newborns of preeclamptic mothers with RDS

  2013cites this paper
• The role of VEGF and other parameters in tracking the clinical course in metronomic chemotherapy.

  2013cites this paper
• Assessment of Cord Blood Vascular Endothelial Growth Factor Levels and Circulating CD34+ Cells in Preterm Infants with Respiratory Distress Syndrome

  2012cites this paper
• VEGF levels in humans and animal models with RDS and BPD: Temporal relationships

  2012cites this paper
• Correlation of 2-Methoxyestradiol Levels in Cord Blood and Complications of Prematurity

  2010cites this paper
• Modeling the neurovascular niche: implications for recovery from CNS injury.

  2009cites this paper
• Developmental regulation of NO-mediated VEGF-induced effects in the lung.

  2008cites this paper
• VEGF als Indikator einer transfusionsbeduerftigen Anaemie bei Neugeborenen

  2008influential citation
• Retinal Angiogenesis and Growth Factors

  2007cites this paper
• Principles and therapeutic implications of angiogenesis, vasculogenesis and arteriogenesis.

  2006cites this paper
• Potential clinical applications using stem cells derived from human umbilical cord blood.

  2006cites this paper
• Inflammation and bronchopulmonary dysplasia: a continuing story.

  2006cites this paper